-
On July 18, 2008, the Food and Drug Administration (FDA) approved changes to the package insert for abacavir sulfate (Ziagen) highlighting information about the association of the HLA-B*5701 allele (a part of a gene) and hypersensitivity reactions (HSR) caused by abacavir-containing therapy.
-
Study results show that concerns about side effects may prevent patients from seeking treatment.
-
The World Health Organization (WHO) has created a package of priority interventions designed to help low- and middle-income countries move towards universal access to HIV/AIDS prevention, treatment, care and support.
-
Working as an HIV clinician in the United States today is largely about doing more with less.
-
HIV clinicians likely will find the latest version of the government's opportunistic infections (OIs) guidelines to be pertinent to their daily practice. This is especially true as the trend continues of patients being diagnosed with very low CD4 cell counts.
-
Results from the AIDS Treatment for Life International Survey (ATLIS)which polled nearly 3,000 HIV-positive patients from 18 countriesshow people living with HIV and AIDS around the globe still live in fear of the societal stigma that surrounds the disease.
-
The Centers for Disease Control and Prevention has issued recommendations for postexposure interventions to prevent infection with HIV and other bloodborne pathogens among the wounded during mass casualty events.
-
-
-
The child with an inborn error of metabolism often cannot be easily identified. Nonspecific symptoms and relative infrequent occurrence make diagnosis difficult and can lead to potential delays in both recognition and treatment.
